Streetbeat News

Stock Prices

CRM

A significant amount of unusual options activity has been observed for Salesforce (NYSE:CRM), indicating a bullish stance by a large investor or institution. The overall sentiment of these big-money traders is split between 54% bullish and 45% bearish. The price target for Salesforce over the last 3 months has been between $200.0 to $340.0. Several financial institutions have maintained their Buy or Outperform ratings on Salesforce, with price targets ranging from $250 to $260.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 4:31 pm

COST

Unusual options activity has been observed for Costco Wholesale (NASDAQ:COST), with a bearish stance taken by a large investor. The overall sentiment of these big-money traders is split between 45% bullish and 54% bearish. The whales have been targeting a price range from $435.0 to $560.0 for Costco Wholesale over the last 3 months. The price of COST is up 0.11% at $565.82. Baird, Telsey Advisory Group, and Oppenheimer maintain their Outperform rating on Costco Wholesale, while Citigroup downgraded its action to Neutral.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 4:31 pm

VIEW

View Inc. has announced a 60-for-1 reverse stock split which is expected to become effective for trading on July 27, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2023 | 4:31 pm

INTU

Intuit (NASDAQ:INTU) has outperformed the market over the past 5 years, producing an average annual return of 19.45%. If an investor had bought $1000 of INTU stock 5 years ago, it would be worth $2,450.44 today.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 4:30 pm

DXCM

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 24.76% on an annualized basis, producing an average annual return of 33.65%. If an investor had bought $1000 of DXCM stock 15 years ago, it would be worth $74,676.22 today.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 4:30 pm

ABVC

AURC

BA

DXF

MXL

SIMO

VICR

U.S. stocks traded mixed with the Dow Jones gaining around 50 points. Boeing Co reported better-than-expected Q2 results with an 18% YoY revenue increase to $19.75 billion. Silicon Motion Technology Corporation shares shot up 79% following a report suggesting China approval of the company's Maxlinear merger. ABVC BioPharma shares shot up 42% after signing a term sheet to advance a partnership with Zhonghui United Technology Group Co., Ltd. Vicor Corporation shares gained 52% after posting better-than-expected Q2 results. Dunxin Financial Holdings Limited shares dropped 43% after reporting pricing of $1.09 million registered direct offering. Aurora Acquisition Corp. shares were down 20% after jumping over 220% on Tuesday. MaxLinear, Inc. was down, falling 19% following a report suggesting China approval of the company's Silicon Motion merger.

Portfolio Pulse from Lisa Levin

July 26, 2023 | 4:29 pm

MNK

Mallinckrodt Plc (NYSE:MNK) is reportedly considering pulling out of a $1.7 billion settlement related to the opioid crisis, with $1.3 billion still outstanding. Hedge funds that backed the company, including Silver Point Capital, Bracebridge Capital and Alta Fundamental Advisers, are negotiating with the board to take control of the business through a bankruptcy declaration. The funds argue that the settlement could harm the company's financial stability and breach its legal obligations to investors.

Portfolio Pulse from Vandana Singh

July 26, 2023 | 4:28 pm

VIV

Telefonica Brasil's shares are trading higher after the company reported better-than-expected Q1 earnings.

Portfolio Pulse from Bill Haddad

July 26, 2023 | 4:27 pm

ABBV

AMGN

AbbVie's drug Skyrizi has shown superiority over Amgen's Otezla in a head-to-head Phase 4 study for moderate plaque psoriasis. The study achieved all primary and ranked secondary endpoints without identifying new safety signals. Skyrizi is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.

Portfolio Pulse from Vandana Singh

July 26, 2023 | 4:25 pm

MSFT

Microsoft Corp (NASDAQ:MSFT) shares are trading lower after the company reported Q4 financial results. Analysts from BMO, RBC Capital Markets, Wedbush, Needham, and Piper Sandler provided their insights. Azure growth deceleration was noted, but AI growth could benefit the company. The impact of AI's contribution to revenue could be gradual. The growth of Microsoft Teams was highlighted. Microsoft's first-mover advantage in generative AI was also noted.

Portfolio Pulse from Chris Katje

July 26, 2023 | 4:25 pm